Epix Resubmits NDA for Vasovist

EPIX Pharmaceuticals … announced that the New Drug Application for its novel blood pool magnetic resonance angiography agent, Vasovist (gadofosveset trisodium) was resubmitted to the U.S. Food and Drug Administration on June 30, 2008.
Fox Business